News
ABBV
--
0.00%
--
Top Research Reports for Home Depot, Toyota & IBM
Today's Research Daily features new research reports on 16 major stocks, including The Home Depot (HD), Toyota Motor (TM), and International Business Machines (IBM).
Zacks.com · 4h ago
AbbVie (ABBV) Stock Sinks As Market Gains: What You Should Know
Zacks · 4h ago
AbbVie Inc. stock falls Tuesday, underperforms market
Shares of AbbVie Inc. shed 0.03% to $108.22 Tuesday, on what proved to be an all-around mixed trading session for the stock market, with the S&P 500 Index...
marketwatch.com · 6h ago
Cannabis Pharmaceutical Market Is Expected To Witness Faster Growth During The Forecast Period 2021-2030 In Asia Pacific - Report By Acumen Research And Consulting
LOS ANGELES, April 13, Apr 13, 2021 (GLOBE NEWSWIRE via COMTEX) -- Acumen Research and Consulting, a global provider of market research studies, recently...
GlobeNewswire · 10h ago
T-Cell Therapy Market Demand, Growth, Trend, Business Opportunities, CAGR of 14.9%, Manufacturers and Research Methodology by 2027
Market Insight Reports · 12h ago
Taking It Easy Before Earnings
Zacks · 13h ago
What's in Store for Edwards Lifesciences (EW) in Q1 Earnings?
Zacks.com · 13h ago
Global Breakthrough Therapy (BT) Designation Market – Top Participant To Focus On Regional Expansion
Market Insight Reports · 13h ago
Top 50 Biosimilar Drug Manufacturers 2021
GlobeNewswire · 16h ago
Pharmaceutical Contract Manufacturing Market Report 2020-2030
GlobeNewswire · 17h ago
Pharmaceutical Contract Manufacturing Market Growth, Global Survey, Analysis, Share, Company Profiles and Forecast by 2026
Apr 13, 2021 (Market Insight Reports) -- Rising demand for generic formulations, increased investments in pharmaceutical Research & Development and...
Market Insight Reports · 19h ago
Leukemia Therapeutics Market by Application & Type – Global Forecast 2028
Apr 13, 2021 (AmericaNewsHour) -- Research Nester has released a report titled "Leukemia Therapeutics Market - Global Demand Analysis & Opportunity...
AmericaNewsHour · 19h ago
Global China Tumor Necrosis Factor (TNF) Inhibitor Drugs Market Size, Share, Value, and Competitive Landscape 2024 .
Heraldkeepers · 20h ago
Prostate Cancer Therapeutics Market Size Set to Register 7.68% CAGR and by 2027
Apr 12, 2021 (Market Insight Reports) -- Selbyville, Delaware Market Study Report LLC recently added a new title on Prostate Cancer Therapeutics Market...
Market Insight Reports · 1d ago
AbbVie Inc. stock rises Monday, outperforms market
Shares of AbbVie Inc. inched 0.66% higher to $108.25 Monday, on what proved to be an all-around grim trading session for the stock market, with the S&P 500...
marketwatch.com · 1d ago
COVID SCIENCE-Autoimmune-disease drugs may reduce vaccine response; antibody treatments ineffective vs Brazil variant
reuters.com · 1d ago
Global Cystic Fibrosis Therapeutics Market – Growing Trade Among Emerging Economies Opening New Opportunities
Apr 12, 2021 (Market Insight Reports) -- New York, US, The business report released by Zion Market Research on Global Cystic Fibrosis Therapeutics Market...
Market Insight Reports · 1d ago
Global Prescription Dermatology Therapeutics Market – Top Participant To Focus On Regional Expansion
Apr 12, 2021 (Market Insight Reports) -- New York, US, The business report released by Zion Market Research on Global Prescription Dermatology Therapeutics...
Market Insight Reports · 1d ago
What Makes AbbVie (ABBV) a New Buy Stock
AbbVie (ABBV) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Zacks · 1d ago
AbbVie (ABBV) is a Top Dividend Stock Right Now: Should You Buy?
Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does AbbVie (ABBV) have what it takes? Let's find out.
Zacks · 1d ago
Webull provides a variety of real-time ABBV stock news. You can receive the latest news about AbbVie through multiple platforms. This information may help you make smarter investment decisions.
About ABBV
AbbVie Inc. (AbbVie) is a research-based biopharmaceutical company. The Company is engaged in the discovery, development, manufacture and sale of a range of pharmaceutical products. Its products are focused on treating conditions, such as chronic autoimmune diseases in rheumatology, gastroenterology and dermatology; oncology, including blood cancers; virology, including hepatitis C virus (HCV) and human immunodeficiency virus (HIV); neurological disorders, such as Parkinson's disease and multiple sclerosis; metabolic diseases, including thyroid disease and complications associated with cystic fibrosis, and other serious health conditions. It offers products in various categories, including HUMIRA (adalimumab), Oncology products, Virology Products, Additional Virology products, Metabolics/Hormones products, Endocrinology products and other products, which include Duopa and Duodopa (carbidopa and levodopa), Anesthesia products and ZINBRYTA (daclizumab).